Epigastric Pain Causes and Diagnostic Approach

Gastrointestinal Causes

• The American College of Radiology suggests that gastroesophageal reflux disease (GERD) presents with epigastric pain often accompanied by heartburn and regurgitation, affecting approximately 7% of Americans daily and 42% at least once monthly 1
• Esophagitis manifests as fine nodularity or granularity of the mucosa, erosions or ulcers, thickened longitudinal folds, inflammatory esophagogastric polyps, and scarring with strictures 2
• Gastritis appears as enlarged areae gastricae, disruption of normal polygonal areae gastricae pattern by multiple uniform nodules, thickened gastric folds, or erosions 2
• Peptic ulcer disease has an incidence of 0.1% to 0.3% and can present with epigastric pain not relieved by antacids 1
• Hiatal hernia can be detected on imaging studies and may contribute to reflux symptoms 2
• Gastric cancer may present with an ulcer associated with nodularity of the adjacent mucosa 2

Non-Gastrointestinal Causes

• Myocardial infarction can present with epigastric pain and should be considered in the differential diagnosis, especially with risk factors and exertional symptoms 1
• Acute aortic syndromes can cause sudden, severe epigastric pain 1

Pregnancy-Specific Considerations

• Preeclampsia can present with epigastric or right upper quadrant pain, headaches, visual changes, or swelling 3
• HELLP syndrome should be considered with epigastric pain, nausea, vomiting, and malaise in pregnant patients 3
• Acute fatty liver of pregnancy may present with malaise, headache, nausea, vomiting, jaundice, and epigastric pain 3

Diagnostic Approach

Clinical Assessment

• Evaluate timing and onset of pain (sudden vs. gradual) 3
• Assess severity on a scale of 1-10 3
• Inquire about associated symptoms: nausea, vomiting, hematemesis, heartburn, regurgitation 3
• Check for alarm symptoms: weight loss, anemia, dysphagia, persistent vomiting 1

Imaging Considerations

• CT abdomen with IV contrast can help diagnose complications such as perforation, showing findings like:
  • Extraluminal gas (97% of perforations) 4
  • Fluid or fat stranding along gastroduodenal region (89%) 4
  • Ascites (89%) 4
  • Focal wall defect and/or ulcer (84%) 4
  • Wall thickening (72%) 4
• Fluoroscopic studies like barium esophagram or upper GI series can provide anatomic and functional information for GERD and esophagitis 2

Complications to Watch For

• PUD-related complications occur in 2-10% of cases, with perforation having a mortality rate of up to 30% 1
• Bleeding is the most common complication of duodenal ulcers and can present as hematemesis 5
• Perforation presents with sudden, severe epigastric pain that may generalize, accompanied by fever and abdominal rigidity, requiring immediate surgical intervention 5

Diagnosis and Management of Epigastric Pain with Vomiting

Critical Warning Signs and Initial Assessment

• The presence of persistent vomiting with epigastric pain and burning warrants urgent evaluation for serious organic pathology, as vomiting suggests another disorder beyond functional disease, according to the Rome IV criteria 6, 7
• Persistent vomiting is a red flag that excludes functional dyspepsia and mandates investigation for structural disease, such as peptic ulcer disease or acute coronary syndrome 6, 7
• The American Heart Association recommends obtaining an ECG to exclude myocardial ischemia, particularly in women, diabetics, and elderly patients who may present atypically with epigastric pain and vomiting 8
• Checking vital signs immediately for tachycardia ≥110 bpm, fever ≥38°C, or hypotension is crucial, as these predict anastomotic leak, perforation, or sepsis with high specificity 9

Diagnostic Workup and Laboratory Tests

• The World Journal of Emergency Surgery recommends ordering complete blood count, C-reactive protein, serum lactate levels, liver and renal function tests, and serum amylase or lipase to exclude acute pancreatitis 9, 10
• Serum amylase (≥4x normal) or lipase (≥2x normal) should be checked to exclude acute pancreatitis, with a sensitivity and specificity of 80-90% 10

Initial Treatment Approach

• The American Gastroenterological Association recommends starting high-dose proton pump inhibitor therapy immediately, with omeprazole 20-40 mg once daily before meals, while awaiting diagnostic workup 11
• Full-dose PPI therapy is first-line for ulcer-like dyspepsia, with a healing rate of 80-90% for duodenal ulcers and 70-80% for gastric ulcers 11

Common Pitfalls to Avoid

• The Rome IV criteria state that persistent vomiting likely suggests another disorder and should not be attributed to epigastric pain syndrome, with a high risk of missing serious pathology 6, 7
• Delaying endoscopy in patients with alarm features, such as persistent vomiting, weight loss, anemia, dysphagia, or age-dependent risk factors for gastric cancer, can lead to poor outcomes 6, 7, 11
• Missing cardiac causes of epigastric pain, such as acute coronary syndrome, can be fatal, with a mortality rate of 10-20% 8

Diagnostic Approach for Epigastric Pain and Nausea

Essential Laboratory Testing and Management

• The American College of Gastroenterology recommends serum electrolytes and glucose testing for patients with epigastric pain and nausea, with the goal of identifying underlying causes and guiding management 12
• Serum electrolytes and glucose, as well as liver function tests and urinalysis, are essential laboratory tests to order immediately for patients with epigastric pain and nausea, as recommended by Gastroenterology guidelines 12
• For symptomatic relief of nausea, ondansetron 8 mg sublingual every 4-6 hours, promethazine 12.5-25 mg orally/rectally every 4-6 hours, and prochlorperazine 5-10 mg every 6-8 hours are recommended, with a baseline ECG obtained before administering ondansetron due to QTc prolongation risk 12

Severe Epigastric Pain with Vomiting: Life-Threatening Conditions

Immediate Life-Threatening Causes

• The American Gastroenterological Association recommends that overall mortality for acute pancreatitis is <10% but reaches 30-40% in necrotizing pancreatitis, with a high level of evidence 13
• Mesenteric ischemia is a life-threatening condition that must be excluded, particularly in elderly patients with vascular risk factors and pain out of proportion to examination, with a moderate level of evidence 13
• A leaking abdominal aortic aneurysm is a life-threatening condition that must be excluded, especially in patients over 50 years with vascular risk factors, with a moderate level of evidence 13
• Chest and abdominal plain x-rays can help exclude perforated viscus and intestinal obstruction, with a low level of evidence 13

Diagnosis and Management of Epigastric Discomfort

Immediate Assessment and Diagnostic Workup

• The British Society of Gastroenterology recommends non-urgent endoscopy for treatment-resistant dyspepsia in patients ≥55 years, but the presence of epigastric tenderness on examination and prolonged symptom duration warrants consideration of earlier endoscopy 14, 15
• Weight loss is an alarm feature that mandates urgent endoscopy, requiring objective evidence 14
• Anemia on complete blood count is an indicator for urgent endoscopy 15
• Dysphagia or sensation of food sticking at a specific level is an alarm feature that requires urgent endoscopy 14
• The presence of epigastric tenderness suggests organic pathology rather than functional disease 15

Diagnostic Imaging

• Fluoroscopy upper GI series can detect ulcers, gastritis, and hiatal hernias, but is less sensitive than endoscopy 16, 17

Management and Treatment

• Delaying endoscopy in high-risk patients with persistent symptoms beyond 8 weeks with tenderness is a common pitfall to avoid, and endoscopy is warranted regardless of age 14, 15

Evidence‑Based Differential Diagnosis of Post‑Prandial Abdominal Pain in Adolescents

Inflammatory Bowel Disease (IBD)

• Pediatric‑onset IBD accounts for 10–15 % of all IBD cases presenting before age 18, making it a high‑priority consideration in adolescents with post‑prandial pain. 18
• Pediatric IBD exhibits distinct phenotypic features that can delay diagnosis and treatment compared with adult‑onset disease. 18
• In children with ulcerative colitis, extensive colitis occurs in 42–90 % of cases, and atypical findings such as patchy inflammation or rectal sparing are seen in up to 30 % of patients. 18
• Peri‑appendiceal inflammation does not reliably differentiate Crohn’s disease from ulcerative colitis and should still prompt consideration of Crohn’s disease. 18
• Endoscopic evaluation of the upper and lower gastrointestinal tracts with mucosal biopsies remains the gold standard for diagnosing IBD in this age group. 18
• Clinical guidance advises against assuming functional dyspepsia without first excluding IBD, given the relatively high prevalence of organic disease in adolescents. 18

Peptic Ulcer Disease (PUD)

• PUD accounts for approximately 10 % of upper‑gastrointestinal symptoms in the general dyspeptic population. 19
• More than 50 % of patients with gastroesophageal reflux disease (GERD) lack endoscopic evidence of esophagitis, underscoring the need for careful clinical assessment. 19

Functional Dyspepsia

• When organic pathology is excluded, the majority of dyspeptic adolescents are diagnosed with functional dyspepsia after endoscopic evaluation. 19
• Rome IV criteria define functional dyspepsia as the presence of one or more of the following symptoms for at least six months, with no structural disease on endoscopy: bothersome epigastric pain, epigastric burning, post‑prandial fullness, or early satiation. 20
• The post‑prandial distress syndrome subtype requires bothersome post‑prandial fullness or early satiation occurring at least three days per week. 20
• Persistent vomiting is a red‑flag sign and should prompt evaluation for non‑functional causes rather than being attributed to functional dyspepsia. 20

Diagnostic and Management Recommendations

• H. pylori testing (13C‑urea breath test or stool antigen) should be performed when peptic ulcer disease is suspected. 19
• Endoscopic assessment is indicated for adolescents with persistent symptoms beyond eight weeks and epigastric tenderness, regardless of age. (Guideline recommendation inferred from evidence on functional vs. organic differentiation.) 18

Strength of evidence: The cited studies provide observational and expert‑consensus data; specific grading (e.g., GRADE) was not reported in the source material.

Evaluation of New‑Onset Epigastric Pain and Vomiting – Evidence‑Based Recommendations

Alarm Features Indicative of Serious Organic Pathology

• Persistent vomiting, unexplained weight loss, anemia on complete blood count, dysphagia, hematemesis, and epigastric tenderness are considered alarm features that warrant urgent investigation. 21

Diagnostic Pathway for Patients With Alarm Features (≥55 years or any alarm sign)

• After exclusion of surgical emergencies by contrast‑enhanced CT of the abdomen and pelvis, an urgent upper endoscopy should be performed to identify mucosal lesions such as peptic ulcer disease or malignancy. 21

Diagnostic Pathway for Patients Without Alarm Features (<55 years)

• When CT and laboratory studies rule out surgical emergencies, non‑invasive testing for Helicobacter pylori should be performed using a ^13C‑urea breath test or stool antigen assay; serology is not recommended. 21

Therapeutic Management Based on H. pylori Status

• If H. pylori is detected: initiate a standard eradication regimen (e.g., clarithromycin‑based triple therapy or bismuth‑based quadruple therapy). 21
• If H. pylori is negative or symptoms persist after eradication: start empirical proton‑pump inhibitor (PPI) therapy with omeprazole 20–40 mg once daily taken before meals for a duration of 4–8 weeks. 21

Role of High‑Dose PPI Therapy

• High‑dose omeprazole (20–40 mg daily) achieves ulcer healing rates of approximately 80–90 % for duodenal ulcers and 70–80 % for gastric ulcers. 21

Evidence‑Based Guidelines for Evaluating Dyspepsia and Heartburn

Diagnostic Criteria

• GERD is defined by the American Gastroenterological Association as heartburn occurring more than once weekly. This criterion should be applied as the primary working diagnosis when heartburn is present. 22
• Dyspepsia is defined as chronic or recurrent pain or discomfort centered in the upper abdomen. This definition guides the work‑up when epigastric pain dominates. 22, 23

Endoscopic Findings

• More than 50 % of patients with GERD have a normal endoscopy (non‑erosive reflux disease); therefore, the absence of esophagitis does not exclude GERD. Endoscopic assessment should not be used to rule out the disease. 22, 23

Epidemiology & Prevalence

• Functional dyspepsia accounts for the majority (>50 %) of patients undergoing endoscopy for dyspepsia. It is the most common functional gastrointestinal disorder in this setting. 22, 23
• Peptic ulcer disease explains approximately 10 % of all upper‑gastrointestinal symptoms. This proportion informs the relative priority of ulcer testing. 22, 23

Etiology

• Helicobacter pylori infection is the principal cause of peptic ulcers that are not related to NSAID use. Eradication testing should be considered in ulcer work‑up. 22, 23
• Gastritis may be either H. pylori‑related or induced by NSAID use. Both mechanisms should be evaluated when gastritis is suspected. 22
• NSAID‑induced gastropathy or ulceration is a recognized medication‑related cause of dyspeptic symptoms. A thorough medication history is essential. 22, 23

Alarm Features Requiring Urgent Endoscopy

• Age ≥ 55 years with new‑onset dyspeptic or heartburn symptoms constitutes an alarm feature that mandates prompt endoscopic evaluation. This threshold helps identify patients at higher risk for serious pathology. 22

All bullet points are supported by the cited references and reflect the current evidence as presented by the American Gastroenterological Association.

Perforated Peptic Ulcer: Diagnosis and Outcomes

Prognosis

• In patients with a perforated peptic ulcer, delayed treatment is associated with a mortality rate of approximately 30 % 24.

Imaging Modalities

• Computed tomography (CT) of the abdomen and pelvis with intravenous contrast is the diagnostic gold standard for suspected perforated peptic ulcer, demonstrating:

  CT Finding	Frequency in Confirmed Cases
  Extraluminal free gas	97 %
  Fluid or fat stranding	89 %
  Ascites	89 %
  Focal wall defect	84 %

• When CT is unavailable or cannot be performed promptly, a chest and abdominal X‑ray should be obtained as an initial assessment to detect free intraperitoneal air, providing a useful alternative screening tool 24.

Diagnosis and Management of Upper Gastrointestinal Disorders

GERD (Gastroesophageal Reflux Disease)

• The American Academy of Pediatrics states that GERD can be diagnosed clinically in adolescents and adults when typical symptoms (heartburn or acid regurgitation) occur more than once weekly【25】.
• The American Gastroenterological Association recommends that endoscopy is not required for diagnosing uncomplicated GERD【25】【26】.

Dyspepsia Definitions

• The British Society of Gastroenterology defines dyspepsia as chronic or recurrent upper‑abdominal pain or discomfort lasting at least 8 weeks【27】【28】.

Functional Dyspepsia

• Functional dyspepsia is diagnosed when dyspeptic symptoms are bothersome for > 8 weeks and endoscopy shows no structural disease【27】【28】.
• It accounts for approximately 80 % of patients with dyspepsia after endoscopic investigation【27】.
• Up to 50 % of functional dyspepsia patients have overlapping irritable bowel syndrome, but the pain is unrelated to defecation【27】.

Peptic Ulcer Disease (PUD)

• The American Gastroenterological Association specifies that definitive diagnosis of PUD requires endoscopic visualization of an ulcer crater in the stomach or duodenum【26】.
• Clinical symptoms alone cannot reliably distinguish PUD from functional dyspepsia【27】.

“Hyperacidity”

• The British Society of Gastroenterology notes that “hyperacidity” is not a recognized diagnostic entity in current gastroenterology guidelines【27】【28】【26】.

Alarm Features Requiring Urgent Endoscopy

• The British Society of Gastroenterology lists the following alarm features that mandate a 2‑week‑wait endoscopy:

Diagnostic Approach for Patients Without Alarm Features

Predominant Heartburn/Regurgitation

• Initiate empiric proton‑pump inhibitor (PPI) therapy (omeprazole 20–40 mg once daily before meals) for 4–8 weeks【25】【26】.
• Endoscopy is not required for initial diagnosis【25】【26】.
• If symptoms persist after 8 weeks of twice‑daily PPI, schedule endoscopy【26】.

Predominant Epigastric Pain/Discomfort

• Perform H. pylori testing using validated non‑invasive methods (¹³C‑urea breath test or stool antigen; serology is not recommended)【27】.
• If H. pylori‑positive, treat with standard eradication regimens.
• If H. pylori‑negative or symptoms persist after eradication, commence a PPI trial (omeprazole 20–40 mg daily) for 4–8 weeks.
• Persistent symptoms beyond 8 weeks despite therapy warrant endoscopy【27】.

Endoscopic Findings and Their Diagnostic Implications

• Esophagitis on endoscopy confirms erosive GERD【25】【26】.
• Ulcer crater confirms PUD; biopsies should be taken for H. pylori detection【26】.
• Normal mucosa in a patient with dyspeptic symptoms supports a diagnosis of functional dyspepsia【27】【28】.
• Normal mucosa with isolated heartburn suggests non‑erosive reflux disease (NERD)【25】.

Recommended Diagnostic Tests

Common Diagnostic Pitfalls

• Not asking the patient which symptom is most bothersome leads to misclassification and inappropriate therapy【27】.
• Delaying endoscopy in patients aged ≥ 55–60 years despite new‑onset symptoms is a frequent error; age alone is an alarm feature【27】.
• Attributing persistent vomiting to functional dyspepsia ignores its status as a red‑flag for organic disease【27】【28】.
• Ordering an upper GI series to diagnose GERD or dyspepsia is unsupported and may produce false‑positive results【25】.

All facts are derived from peer‑reviewed guidelines and carry the level of evidence reported in the original sources (generally expert consensus or moderate‑quality evidence, as no specific grading was provided).

Diagnostic and Management Guidelines for Acute Epigastric Pain with Overlapping Gastroenteritis and GERD

1. Initial Diagnostic Evaluation

• In adults presenting with acute epigastric pain and diarrhea, acute infectious gastroenteritis is the most likely diagnosis, but peptic ulcer disease must be excluded and an electrocardiogram obtained to rule out atypical myocardial infarction. 29
• A complete blood count should be ordered to identify anemia, which is an alarm feature that mandates urgent endoscopy. 29
• Helicobacter pylori testing using a ^13C‑urea breath test or stool antigen (serology is not recommended) is mandatory for any patient with epigastric pain because eradication eliminates the mortality risk associated with peptic ulcer disease. 29
• Epigastric tenderness on both direct and indirect palpation indicates organic pathology rather than functional dyspepsia and warrants further investigation irrespective of patient age. 30

2. Red‑Flag Features and Indications for Endoscopy

3. Initial Therapeutic Measures

• Start high‑dose proton‑pump inhibitor (PPI) therapy immediately (omeprazole 20–40 mg once daily before meals) while diagnostic work‑up is pending. 31
• Full‑dose PPI therapy achieves 80–90 % healing of duodenal ulcers and 70–80 % healing of gastric ulcers within 4 weeks. 31

4. Lifestyle and Risk‑Factor Modification

• Advise patients to remain upright for at least 2–3 hours after meals (avoid lying down within 45 minutes) to reduce gastro‑esophageal reflux symptoms. 31
• Reduce regular coffee consumption, as caffeine increases gastric acid secretion and worsens reflux. 31
• Limit intake of citrus fruits, which commonly trigger dyspeptic symptoms. 30
• Encourage weight loss in patients with severe obesity, as this markedly improves reflux and lowers intra‑abdominal pressure. 29

5. Follow‑Up and Ongoing Management

• If symptoms resolve within 4–8 weeks, consider tapering and withdrawing PPI therapy, reserving on‑demand use for recurrence. 31
• Confirm H. pylori eradication with a repeat stool antigen or breath test 4 weeks after completing therapy. 29
• Continue lifestyle modifications (upright posture after meals, reduced coffee/citrus intake, weight loss) as part of long‑term management. 31
• If symptoms persist beyond 4–8 weeks, refer for non‑urgent endoscopy to exclude peptic ulcer disease, gastritis, or malignancy. 29
• Prior to endoscopy, consider escalating PPI dosing to twice daily (omeprazole 20–40 mg twice daily) to optimize symptom control. 31
• Re‑evaluate for any newly emerging alarm features (weight loss, anemia, persistent vomiting); their presence upgrades the indication to urgent endoscopy. 29

6. Clinical Pearls

• Persistent vomiting is a red‑flag symptom and should not be attributed to functional dyspepsia; it signals possible organic disease. 33
• Physical examination tenderness should prompt timely endoscopic investigation; delaying endoscopy in such cases is discouraged. 32

Evidence‑Based Contributors to Nocturnal Indigestion

Gastrointestinal Factors

• Duodenal ulcer pain typically appears 2–5 hours after a meal or during the night when the stomach is empty, reflecting ulcer‑related mucosal irritation. 34
• Gastroparesis manifests with nausea, vomiting, and post‑prandial fullness that worsen at night because delayed gastric emptying prolongs gastric distension. 34
• Gastroparesis is present in roughly 20–40 % of individuals with long‑standing type 1 diabetes, indicating a strong link between chronic hyperglycemia and impaired gastric motility. 34
• Hyperglycaemia itself induces antral hypomotility and gastric dysrhythmias, further contributing to nocturnal dyspeptic symptoms. 34

Cardiac Factors

• In congestive heart failure, nocturnal redistribution of fluid from peripheral edema to the thorax can precipitate reflux‑type symptoms and dyspnoea, especially when patients lie supine. 35
• Physical examination for ankle swelling and orthopnoea helps identify heart‑failure‑related nocturnal discomfort. 36

Sleep‑Related Disorders

• Obstructive sleep apnoea generates negative intrathoracic pressure during apnoeic episodes, which promotes gastro‑oesophageal reflux and may trigger nocturnal indigestion. 35
• Screening questions such as “Do you gasp or stop breathing at night?” and “Do you wake up without feeling refreshed?” are useful for detecting OSA‑related reflux. 36
• Primary sleep disorders—including insomnia, restless‑legs syndrome, and parasomnias—can cause nocturnal awakenings that are mistakenly attributed to gastrointestinal causes. 35
• Asking patients “Do you have problems sleeping aside from needing to get up or feeling discomfort?” assists in distinguishing sleep‑related from digestive origins. 36

Endocrine and Metabolic Factors

• Diabetes mellitus contributes to nocturnal dyspepsia through both gastroparesis and autonomic neuropathy, which impair oesophageal clearance and gastric motility. 34
• Measurement of glycated haemoglobin (HbA1c) is recommended in any individual presenting with night‑time dyspeptic symptoms to evaluate diabetic control. 36
• Thyroid dysfunction (both hyper‑ and hypothyroidism) can alter gastrointestinal motility, warranting thyroid‑function testing as part of the baseline work‑up. 36

Medication‑Induced Factors

• Calcium‑channel blockers lower lower‑oesophageal sphincter pressure, thereby exacerbating reflux and nocturnal indigestion. 36
• Non‑steroidal anti‑inflammatory drugs (NSAIDs) cause gastropathy and increase the risk of peptic ulcer disease, which can present with night‑time epigastric pain. 36

Renal Factors

• Chronic kidney disease may lead to xerostomia, prompting increased fluid intake that worsens nocturnal reflux symptoms. 36
• Assessment of electrolytes, renal function, and urine albumin‑to‑creatinine ratio is advised when evaluating nocturnal dyspepsia in patients with possible renal impairment. 36

Diagnostic Screening Tools

• A structured “SCREeN” questionnaire incorporating items on sleep‑related breathing disturbances, cardiac swelling, excessive thirst, and neurological leg symptoms improves identification of non‑gastrointestinal contributors to night‑time indigestion. 36

*Baseline laboratory testing for patients with nocturnal dyspepsia should include electrolytes, renal function, HbA1c, thyroid‑function tests, and calcium level to uncover metabolic or medication‑related causes. 36

Evidence‑Based Pharmacologic and Diagnostic Recommendations for Peptic Ulcer Disease in Adults

Antispasmodic Therapy

• Otilonium bromide (Spasmomen) reduces bowel spasm by blocking L‑type and T‑type calcium channels, providing symptomatic relief of crampy abdominal pain in adults with suspected peptic ulcer disease. 37

Indications for Upper Endoscopy

• Adults ≥ 40 years presenting with new or worsening dyspeptic symptoms, epigastric tenderness on examination, diabetes mellitus, and persistent symptoms despite proton‑pump inhibitor therapy should undergo urgent upper endoscopy within two weeks to detect organic pathology such as ulcer disease or malignancy. 38
• If an upper endoscopy has not yet been performed and dyspeptic symptoms persist after 4–8 weeks of standard‑dose proton‑pump inhibitor therapy, escalation to twice‑daily dosing and scheduling of endoscopy are recommended. 38

NSAID Avoidance

• Nonsteroidal anti‑inflammatory drugs, including over‑the‑counter ibuprofen, should be avoided because they worsen peptic ulcer disease and increase the risk of gastrointestinal bleeding. 39

Urgent Endoscopic Evaluation for Severe Early Satiety

Red‑Flag Assessment

• Persistent vomiting is an alarm feature that excludes functional dyspepsia and mandates investigation for structural disease such as peptic ulcer, gastric outlet obstruction, or malignancy. 40

Timing of Upper Endoscopy

• Urgent upper endoscopy should be scheduled within 2 weeks for individuals aged ≥ 55 years or who present any alarm feature (e.g., weight loss, anemia, dysphagia, persistent vomiting, epigastric tenderness). 40

Diagnostic Pathway for Severe Early Satiety

• Patients with severe early satiety (tolerating only one meal per day) require urgent upper endoscopy to exclude mechanical obstruction, followed by gastric emptying scintigraphy if endoscopy is normal. 40

Clinical Pitfalls

• Severe early satiety must not be attributed to functional dyspepsia without first performing endoscopy, because the symptom severity mandates exclusion of organic disease. 40

Evidence‑Based Approach to Recurrent Epigastric Pain

Life‑Threatening Causes that Must Be Excluded First

• Broad differential: Recurrent epigastric pain may arise from cardiac ischemia, acute aortic syndromes, perforated peptic ulcer, acute pancreatitis, mesenteric ischemia, biliary disease, functional dyspepsia, irritable bowel syndrome, eosinophilic esophagitis, inflammatory bowel disease, gastroparesis, gastric malignancy, and other conditions, each requiring a distinct diagnostic and therapeutic pathway. 41
• Cardiac ischemia presentation: Acute myocardial infarction can manifest as isolated epigastric pain, particularly in women, patients with diabetes, and older adults who may lack classic chest discomfort. 41
• Immediate ECG recommendation: An electrocardiogram should be obtained without delay in any individual with epigastric pain accompanied by exertional symptoms, dyspnea, or cardiovascular risk factors. 41
• Acute aortic syndromes: Aortic dissection or a leaking abdominal aortic aneurysm produces sudden, severe epigastric pain and must be ruled out in patients > 50 years old who have vascular risk factors. 41
• Perforated peptic ulcer: Sudden, severe epigastric pain that rapidly spreads, together with fever and abdominal rigidity, signals perforation; delayed surgical intervention is associated with a mortality rate of approximately 30 %. 41
• Acute pancreatitis clue: Pain that radiates to the back together with nausea and vomiting is suggestive of pancreatitis. 41
• Imaging for alarm features: In patients with alarm features (e.g., age ≥ 55 years, weight loss, anemia, vomiting, gastrointestinal bleeding), an urgent contrast‑enhanced CT of the abdomen and pelvis is recommended to detect perforation, malignancy, pancreatitis, or vascular emergencies. 41

Common Gastrointestinal Causes

Irritable Bowel Syndrome (IBS)

• Diagnostic criteria (Rome IV): Recurrent abdominal pain occurring on average ≥ 1 day per week during the preceding 3 months, plus at least two of the following: pain related to defecation, change in stool frequency, and change in stool form. 42
• Distinguishing feature: In IBS, pain is characteristically related to defecation, which differentiates it from epigastric pain syndrome where pain is not defecation‑related. 42
• Temporal requirement: Symptoms must be present for the last 3 months with an onset at least 6 months before the diagnosis is made. 42

Eosinophilic Esophagitis (EoE)

• Population to consider: Young children with feeding difficulties and GERD‑like symptoms, as well as older children and adults who present with dysphagia or food impaction, should be evaluated for EoE. 43
• Typical adult presentation: Intermittent dysphagia (reported in 29–100 % of cases) and food impaction (25–100 %); EoE accounts for roughly 50 % of all esophageal food‑impaction events. 43
• Response to acid suppression: Symptoms are often unresponsive or only partially responsive to proton‑pump inhibitor therapy, helping to distinguish EoE from gastro‑esophageal reflux disease. 43
• Diagnostic delay: The average time from symptom onset to diagnosis is about 4.6 years (range 0–17 years) because clinical features overlap with GERD. 43

Diagnostic Imaging Strategy

• CT abdomen/pelvis with IV contrast: For patients presenting with alarm features, a contrast‑enhanced CT should be performed urgently to identify life‑threatening etiologies such as perforated viscus, pancreatic inflammation, malignant lesions, or vascular pathology. 41

• CT angiography (when indicated): If endoscopic evaluation is nondiagnostic in patients with weight loss and post‑prandial pain, CT angiography is advised to assess for chronic mesenteric ischemia or median arcuate ligament syndrome. 41

All statements are supported by the cited references; the level of evidence was not explicitly specified in the source material.

Acute Coronary Syndrome Evaluation in Patients with Epigastric Burning Pain Radiating to the Neck

Initial Assessment

• Obtain a 12‑lead electrocardiogram within 10 minutes of presentation because myocardial ischemia can present as epigastric burning, especially in women, diabetics, and elderly patients. (American Heart Association & American College of Cardiology) 44, 45
• Measure cardiac troponin levels at presentation (0 h) and again at 6 h; a single troponin measurement is insufficient to rule out acute coronary syndrome. (American Heart Association) 44

Clinical Risk Indicators

• Concurrent epigastric pain and dyspnea doubles the risk of death compared with typical angina and raises sudden cardiac death risk four‑fold, even in patients without known coronary disease. (American Heart Association) 44
• Radiation of pain to the neck, jaw, or shoulder is a classic sign of cardiac ischemia; the sensation may be described as burning, pressure, or tightness rather than “pain.” (European Heart Journal & American College of Cardiology) 46, 45

Diagnostic Findings

• ECG findings that mandate urgent cardiac evaluation include new ST‑segment changes, new left bundle‑branch block, Q waves, or T‑wave inversions. (American Heart Association & American College of Cardiology) 44, 45
• Elevated troponin levels on serial testing confirm myocardial injury; normal serial troponins help exclude NSTEMI. (American Heart Association) 44

High‑Risk Features Requiring Immediate Cardiology Consultation

• Presence of any of the following: ST‑segment changes on ECG, elevated troponins, age > 50 years with new‑onset symptoms, diabetes mellitus, hypertension, or active smoking. (American Heart Association) 44

Immediate Empiric Management (while awaiting definitive diagnosis)

• Chewable aspirin 162–325 mg should be administered when acute coronary syndrome is suspected and no contraindications exist. (American Heart Association) 44
• Sublingual nitroglycerin may be given for suspected cardiac ischemia; however, relief does not definitively differentiate cardiac from esophageal causes. (American Heart Association) 44

Safety Alerts

• Never dismiss cardiac causes in patients with atypical epigastric pain; approximately one‑third of myocardial infarctions present without chest discomfort. (American Heart Association) 44
• Dyspnea accompanying epigastric pain is an ominous sign and should not be attributed to anxiety or reflux without thorough cardiac evaluation. (American Heart Association) 44

Parenteral Opioid Use and Imaging Findings in Acute Epigastric Pain

Diagnostic Imaging Findings

• Ascites is detected on contrast‑enhanced CT in approximately 89 % of patients with perforated peptic ulcer, making it a highly sensitive radiologic sign for this life‑threatening condition. 47

Analgesic Classification

• Tramadol is classified by the World Health Organization as a Level II (moderate‑pain) opioid, and therefore is considered inadequate for the management of severe visceral pain such as that caused by perforated ulcer, pancreatitis, or myocardial ischemia. [47][48]

Indications for Parenteral Opioids

• Patients with severe acute epigastric pain should receive parenteral opioids (intravenous or subcutaneous) to achieve rapid and titratable analgesia. This recommendation is based on expert consensus. [47][48]

Preferred Opioid Agent and Dosing

• Morphine, administered intravenously or subcutaneously at an initial dose of 5–10 mg and titrated to effect, is the most commonly used strong opioid for severe acute pain in this setting. [47][48]

Route of Administration

• Intramuscular injection of opioids should be avoided; intravenous or subcutaneous routes are preferred because they provide faster onset of analgesia and allow more precise titration. 47

H. pylori Infection: Presentation, Diagnosis, and Misattribution to Left Lower‑Quadrant Pain

Typical Presentation

• H. pylori infection most commonly causes epigastric (upper central abdominal) pain rather than left lower‑quadrant discomfort, reflecting its upper‑GI origin. 49
• Associated upper‑GI symptoms include heartburn, nausea, vomiting, and post‑prandial fullness; left‑lower‑quadrant symptoms are not part of the H. pylori symptom complex. 49

Anatomical Distribution

• The bacterium colonizes the gastric mucosa (antrum and body) situated in the epigastrium/left upper quadrant; it does not inhabit the lower intestinal tract, explaining the absence of left‑lower‑quadrant pain. [49][50]

Testing Recommendations

• H. pylori testing is indicated for patients with epigastric pain, dyspepsia, peptic ulcer disease, or gastric MALT lymphoma, but not for isolated left‑lower‑quadrant abdominal pain. 49
• A “test‑and‑treat” approach is appropriate for uninvestigated dyspepsia in populations where H. pylori prevalence is ≥20 %. 49

Clinical Pitfalls

• Attributing isolated left‑lower‑quadrant abdominal pain to H. pylori represents a fundamental misunderstanding of the organism’s anatomical distribution and symptom profile, potentially delaying correct diagnosis and treatment of the true underlying condition. 49

Alternative Diagnoses for Left‑Lower‑Quadrant Pain

• Conditions that more plausibly cause left‑lower‑quadrant pain include diverticulitis, gynecological pathology (e.g., ovarian cysts, endometriosis), urinary‑tract pathology (e.g., kidney stones, infection), and musculoskeletal disorders. 51

GERD Overlap with Epigastric Pain and Symptom Characterization

Epidemiology of Symptom Overlap

• In patients presenting with heartburn, 63–66 % also report concurrent epigastric pain, indicating a high degree of symptom overlap between reflux and upper‑abdominal discomfort. [52][53]54

Clinical Communication Strategies

• Individuals who experience both heartburn and epigastric pain often have difficulty articulating which symptom predominates; clinicians should use descriptive wording (e.g., “burning sensation starting in the epigastrium and rising toward the neck”) to clarify the primary complaint. [52][53]55

Evidence‑Based Guidelines for the Evaluation and Management of Dyspepsia

Epidemiology

• Approximately 80 % of patients presenting with dyspepsia have functional dyspepsia after organic disease is ruled out by endoscopy, indicating that functional disease is the predominant cause in clinical practice. 56
• Functional dyspepsia affects about 7 % of the general population when defined by Rome IV criteria, while overall dyspepsia prevalence ranges from 25 % to 30 %. 56

Organic Causes That Must Be Excluded

Gastro‑esophageal Reflux Disease (GERD)

• GERD accounts for roughly 13 %–20 % of dyspepsia cases identified during endoscopic evaluation; typical manifestations include heartburn or acid regurgitation occurring more than once weekly. 57
• More than 50 % of GERD patients have a normal endoscopic appearance (non‑erosive reflux disease), so the absence of visible esophagitis does not exclude the diagnosis. 58

Peptic Ulcer Disease

• Peptic ulcer disease contributes approximately 8 %–10 % of all upper‑gastrointestinal symptoms in dyspeptic populations. 57
• Regular use of non‑steroidal anti‑inflammatory drugs (NSAIDs) is a principal etiologic factor for peptic ulcer disease, independent of Helicobacter pylori infection. 58

Gastritis

• Endoscopic findings typical of gastritis include enlarged gastric folds, disruption of the normal polygonal mucosal pattern, thickened folds, or erosions. 59

Gastro‑esophageal Malignancy

• Upper‑gastrointestinal cancers represent less than 0.5 % of dyspepsia presentations, but they must be excluded in individuals aged ≥ 55–60 years who develop new‑onset dyspeptic symptoms. 57

Functional Dyspepsia

Definition and Clinical Features

• Functional dyspepsia is characterized by epigastric pain, burning, early satiety, or post‑prandial fullness persisting for more than eight weeks without detectable structural abnormalities on investigation. 60

Pathophysiological Mechanisms (supported by consensus)

• Delayed gastric emptying and impaired fundic accommodation. 57
• Visceral hypersensitivity with heightened response to gastric distension and chemical stimuli. 57
• Alterations in gastric and small‑intestinal microbiota composition. 57
• Central nervous system dysfunction leading to abnormal pain processing. 57
• Low‑grade mucosal inflammation causing immune activation and increased epithelial permeability. 57

Risk Factors

• Female sex, younger age, and high somatization scores increase the likelihood of functional dyspepsia. 56
• Co‑existing anxiety or depressive disorders markedly raise the risk of new‑onset symptoms. 57
• A preceding acute gastroenteritis episode elevates the risk of post‑infectious functional dyspepsia by approximately threefold after six months. 58
• Current smoking and regular NSAID consumption are additional modifiable risk factors. 56
• Overlap with irritable bowel syndrome occurs in up to 50 % of functional dyspepsia patients. 57

Subtype Classification (Rome IV)

• Epigastric Pain Syndrome (EPS): Recurrent epigastric pain or burning occurring at least one day per week. 56
• Post‑prandial Distress Syndrome (PDS): Persistent post‑prandial fullness or early satiety occurring at least three days per week. 56
• Approximately one‑third of patients exhibit features of both EPS and PDS. 57

Alarm Features and Diagnostic Algorithm

• Age ≥ 55–60 years with new dyspeptic symptoms – warrants urgent upper endoscopy within two weeks. 60
• Unintentional weight loss – considered an alarm sign necessitating prompt endoscopic assessment. 60
• Anemia identified on complete blood count – requires expedited investigation for possible organic disease. 60
• Dysphagia (food sticking) – an alarm feature indicating the need for early endoscopy. 61
• Persistent vomiting – signals possible serious pathology and mandates urgent endoscopic evaluation. 58
• Hematemesis or melena – classic alarm signs that should trigger immediate endoscopic investigation. 61

Evaluation in Patients < 55 Years Without Alarm Features

• Perform non‑invasive H. pylori testing using a ^13C urea breath test or stool antigen assay; serologic testing is not recommended. 59
• If the test is positive, initiate eradication therapy for H. pylori. 61

Clinical Pitfalls to Avoid

• Do not postpone endoscopy in patients aged ≥ 55 years with newly appearing dyspeptic symptoms, as age alone constitutes an alarm feature. 60
• Do not dismiss persistent vomiting as functional dyspepsia; it is a red‑flag sign indicating possible organic disease. 58